History
Headquarters located in Limassol Cyprus, Eris Enterprises is a private holding and trading company, started its operations in 2008 and over the years, founded or contributed to the creation of pharmaceutical companies that are focused on developing and marketing various products in various regions and territories.
One of our biggest Projects in the last decade was the foundation and top management of Eris Pharmaceuticals (Australia) Pty Ltd, known as Eris Pharma with Corporate HQ in AU and Regional BD Offices in GR and presence in over 25 countries .
-
2009
Established
Eris Pharmaceuticals (ERIS Pharma) was founded in 2009
-
2010
Ascent Pharmahealth
In 2010, ERIS Pharma entered into a joint venture with Ascent Pharmahealth, ranked 4th Australian generic pharmaceutical company
-
2012
Ascent from Watson
In 2012, a multi-million acquisition of Ascent from Watson (now Actavis) took place, in which ERIS Pharma was included as well.
-
2012
Independent entity
At the end of 2012, ERIS Pharma became an independent entity with a management buyout, exiting Actavis group.
-
2012
FMH Group
In December 2012, FMH Group, a Swiss-based pharma company acquired the majority of the shares of ERIS Pharma.
-
2013
New Business Plan
As of the beginning of 2013, ERIS Pharma started from scratch with a new Business Plan forming two separate Business Units: One for targeting Emerging Markets and one for Australia & New Zealand Markets.
-
2015
Aurobindo Australia
In April 2015, Eris Pharmaceuticals announced the acquisition of Aurobindo Australia
-
2016
Exit the shareholding venture
In end of 2016, Eris Enterprises exited the shareholding venture.